The preferred embodiment are directed to small molecule inhibitors of the IgE response to allergens, which are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic. The preferred embodiments also relate la imidazole molecules that are cellular proliferation inhibitors and thus are Useful as anticancer agents. The preferred embodiments further relate ID small molecules which suppress cytokines and leukocytes.